Collegium Pharmaceutical, Inc. (COLL) Financials
COLL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.1 billion | 1.8 billion |
| March 31, 2026 | 1.7 billion | 1.3 billion |
| Dec. 31, 2025 | 1.7 billion | 1.4 billion |
| Sept. 30, 2025 | 1.6 billion | 1.3 billion |
COLL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 70.8 million | 14.5 million |
| March 31, 2026 | 56.8 million | 10.9 million |
| Dec. 31, 2025 | 122.4 million | 9.8 million |
| Sept. 30, 2025 | 78.3 million | 9.8 million |
COLL Net Income
No data available :(
COLL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 129.5 million | 797.8 million | 5.0 million |
| March 31, 2026 | 421.8 million | 774.0 million | 3.8 million |
| Dec. 31, 2025 | 406.5 million | 906.0 million | 4.1 million |
| Sept. 30, 2025 | 305.7 million | 865.8 million | 4.5 million |
COLL Shares Outstanding
COLL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 496000 | - | 106.6 million | - |
| March 31, 2026 | 270000 | - | 86.4 million | - |
| Dec. 31, 2025 | 689000 | - | 67.6 million | - |
| Sept. 30, 2025 | 188000 | - | 65.6 million | - |
COLL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 199.9 million | 89.6 million |
| March 31, 2026 | 193.5 million | 76.3 million |
| Dec. 31, 2025 | 205.4 million | 77.1 million |
| Sept. 30, 2025 | 209.4 million | 80.2 million |
COLL Revenue by Segment
Graph available only for paid members. Upgrade to see it.
COLL
Price: $23.19
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.27 USD
P/E Ratio: 21.42
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 465500
Ebitda: -13.3 millionMarket Capitalization: 711.3 million